ebomi
Colour theme
Sign in
Insider · CIK 0001372932

DP VII Associates LP

CIK 0001372932 Name as filed on the most recent filing

Filed as DP VII Associates LP (42)

69 transaction lines · from 42 filings · filed 2008-12-11 to 2016-05-27 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

21 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2011-11-21 P, Open-market purchase Clovis Oncology, Inc.CLVS 203,125, acquired Open Form 4 filing 0000904454-11-000631
2011-09-16 P, Open-market purchase Zogenix, Inc.ZGNX 117,392, acquired Open Form 4 filing 0000904454-11-000541
2010-11-29 P, Open-market purchase Zogenix, Inc.ZGNX 157,640, acquired Open Form 4 filing 0000904454-10-000475
2009-12-18 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 4,793, acquired Open Form 4 filing 0000904454-09-000812
2009-12-17 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 12,661, acquired Open Form 4 filing 0000904454-09-000812
2009-11-24 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 5,663, acquired Open Form 4 filing 0000904454-09-000746
2009-11-23 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 17,436, acquired Open Form 4 filing 0000904454-09-000722
2009-11-20 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 29,051, acquired Open Form 4 filing 0000904454-09-000722
2009-11-12 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 7,176, acquired Open Form 4 filing 0000904454-09-000696
2009-11-11 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 6,230, acquired Open Form 4 filing 0000904454-09-000678
2009-11-10 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 9,806, acquired Open Form 4 filing 0000904454-09-000678
2009-08-18 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 1,786, acquired Open Form 4 filing 0000904454-09-000345
2009-08-17 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 8,098, acquired Open Form 4 filing 0000904454-09-000339
2009-08-14 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 3,520, acquired Open Form 4 filing 0000904454-09-000339
2009-08-13 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 1,711, acquired Open Form 4 filing 0000904454-09-000323
2009-08-12 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 53,664, acquired Open Form 4 filing 0000904454-09-000323
2009-08-11 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 13,292, acquired Open Form 4 filing 0000904454-09-000292
2009-07-23 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 81,758, acquired Open Form 4 filing 0000904454-09-000274
2008-12-09 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 20,036, acquired Open Form 4 filing 0000904454-08-000485

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
Relationships on this page
%, Ten percent owner
Ten percent owner

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 21
  • Open-market sale 0
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. DP VII ASSOCIATES LP, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001372932

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.